Abbott Medical Devices
Clinical trials sponsored by Abbott Medical Devices, explained in plain language.
Now part of
Abbott Laboratories
ABT
NYSE
Medical device division of Abbott Laboratories.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New heart valve fix without surgery: 20-Patient trial begins Results expected Sep 2026 (estimated)
- Tiny pacemaker without wires tested in 20 patients Results expected Sep 2026 (estimated)
- New heart mapping tech could improve AFib treatment safety Results expected Nov 2026 (estimated)
- Pacemaker tweak may boost heart function in failure patients Results expected Dec 2026 (estimated)
- New heart stent device tested in japan – could it reduce fractures? Results expected Dec 2026 (estimated)